XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 10 I, 2002, Pages 1004-1011

  Stern, Mariana C ^a   Johnson, Laura R ^a   Bell, Douglas A ^a   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; LYSINE;

ADULT; AGED; ALLELISM; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER CANCER; CANCER RISK; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA DAMAGE; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROTEINS; RISK FACTORS; SMOKING; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 0036800664     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hartge, P., Silverman, D., Hoover, R., Schairer, C., Altman, R., Austin, D., Cantor, K., Child, M., Key, C., Marrett, L. D., et al. Changing cigarette habits and bladder cancer risk: a case-control study. J. Natl. Cancer Inst., 78: 1119-1925, 1987.
2. Burch, J. D., Rohan, T. E., Howe, G. R., Risch, H. A., Hill, G. B., Steele, R., and Miller, A. B. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int. J. Cancer, 44: 622-628, 1989.
3. Clavel, J., Cordier, S., Boccon-Gibod, L., and Hemon, D. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int. J. Cancer, 44: 605-610, 1989.
4. Morrison, A. S., Buring, J. E., Verhoek, W. G., Aoki, K., Leck, I., Ohno, Y., and Obata, K. An international study of smoking and bladder cancer. J. Urol., 131: 650-654, 1984.
5. Taylor, J. A., Umbach, D. M., Stephens, E., Castranio, T., Paulson, D., Robertson, C., Mohler, J. L., and Bell, D. A. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res., 58: 3603-3610, 1998.
6. Vineis, P., Talaska, G., Malaveille, C., Bartsch, H., Martone, T., Sithisarankul, P., and Strickland, P. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int. J. Cancer, 65: 314-316, 1996.
7. Vineis, P. Epidemiology of cancer from exposure to arylamines. Environ. Health Perspect., 102 (Suppl. 6): 7-10, 1994.
8. Kadlubar, F. F., and Badawi, A. F. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol. Lett., 82-83: 627-632.
9. Hirvonen, A. Chapter 20. Polymorphic NATs and Cancer Predisposition. IARC Sci. Publ., 148: 251-270, 1999.
10. Marcus, P. M., Hayes, R. B., Vineis, P., Garcia-Closas, M., Caporaso, N. E., Autrup, H., Branch, R. A., Brockmoller, J., Ishizaki, T., Karakaya, A. E., Ladero, J. M., Mommsen, S., Okkels, H., Romkes, M., Roots, I., and Rothman, N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol. Biomarkers Prev., 9: 461-467, 2000.
11. Hein, D. W., Doll, M. A., Fretland, A. J., Leff, M. A., Webb, S. J., Xiao, G. H., Devanaboyina, U. S., Nangju, N. A., and Feng, Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev., 9: 29-42, 2000.
12. Berwick, M., and Vineis, P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst., 92: 874-897, 2000.
13. Sung, P., Bailly, V., Weber, C., Thompson, L. H., Prakash, L., and Prakash, S. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature, 365: 852-855, 1993.
14. Lehmann, A. R. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev., 15: 15-23, 2001.
15. Weber, C. A., Salazar, E. P., Stewart, S. A., and Thompson, L. H. Molecular cloning and biological characterization of a human gene, ERCC2, that corrects the nucleotide excision repair defect in CHO UV5 cells. Mol. Cell. Biol., 8: 1137-1146, 1988.
16. Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., and Harris, C. C. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev., 10: 1219-1232, 1996.
17. Shen, H., Xu, Y., Qian, Y., Yu, R., Qin, Y., Zhou, L., Wang, X., Spitz, M. R., and Wei, Q. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer, 88: 601-606, 2000.
18. Lunn, R. M., Helzlsouer, K. J., Parshad, R., Umbach, D. M., Harris, E. L., Sanford, K. K., and Bell, D. A. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis (Lond.), 21: 551-555, 2000.
19. Moller, P., Wallin, H., Dybdahl, M., Frentz, G., and Nexo, B. A. Psoriasis patients with basal cell carcinoma have more repair-mediated DNA strand-breaks after UVC damage in lymphocytes than psoriasis patients without basal cell carcinoma. Cancer Lett., 151: 187-192, 2000.
20. Spitz, M. R., Wu, X., Wang, Y., Wang, L. E., Shete, S., Amos, C. I., Guo, Z., Lei, L., Mohrenweiser, H., and Wei, Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res., 61: 1354-1357, 2001.
21. Duell, E. J., Wiencke, J. K., Cheng, T. J., Varkonyi, A., Zuo, Z. F., Ashok, T. D., Mark, E. J., Wain, J. C., Christiani, D. C., and Kelsey, K. T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis (Lond.), 21: 965-971, 2000.
22. Seker, H., Butkiewicz, D., Bowman, E. D., Rusin, M., Hedayati, M., Grossman, L., and Harris, C. C. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res., 61: 7430-7434, 2001.
23. Stem, M. C., Umbach, D. M., van Gils, C. H., Lunn, R. M., and Taylor, J. A. DNA repair gene XRCC1 polymorphisms, smoking and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 10: 125-131, 2001.
24. Fleiss, J. L. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons, 1981.
25. Weir, B. S. Genetic Data Analysis II. Sunderland, MA: Sinauer Associates, Inc. Publishers, 1996.
26. Hosmer, D. W., and Lemeshow, S. Applied logistic regression. New York: John Wiley & Sons, 1989.
27. Piegorsch, W. W., Weinberg, C. R., and Taylor, J. A. Non-hierarchical logistic models and case-only designs assessing susceptibility in population-based case-control studies. Stat. Med., 13: 153-162, 1994.
28. Khoury, M. J., and Flanders, W. D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol., 144: 207-213, 1996.
29. Coin, F., Marinoni, J. C., Rodolfo, C., Fribourg, S., Pedrini, A. M., and Egly, J. M. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat. Genet., 20: 184-188, 1998.
30. Coin, F., Bergmann, E., Tremeau-Bravard, A., and Egly, J. M. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J., 18: 1357-1366, 1999.
31. Taylor, E. M., Broughton, B. C., Botta, E., Stefanini, M., Sarasin, A., Jaspers, N. G., Fawcett, H., Harcourt, S. A., Arlett, C. F., and Lehmann, A. R. Xeroderma pigmentosum and trichothiodys trophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl. Acad. Sci. USA, 94: 8658-8663, 1997.
32. Umbach, D. M., and Weinberg, C. R. Designing and analysing case-control studies to exploit independence of genotype and exposure. Stat. Med., 16: 1731-1743, 1997.
33. Matullo, G., Guarrera, S., Carturan, S., Peluso, M., Malaveille, C., Davico, L., Piazza, A., and Vineis, P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer, 92: 562-567, 2001.
34. Dybdahl, M., Vogel, U., Frentz, G., Wallin, H., and Nexo, B. A. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 8: 77-81, 1999.
35. Tomescu, D., Kavanagh, G., Ha, T., Campbell, H., and Melton, D. W. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis, 22: 403-408, 2001.
36. Caggana, M., Kilgallen, J., Conroy, J. M., Wiencke, J. K., Kelsey, K. T., Miike, R., Chen, P., and Wrensch, M. R. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol. Biomarkers Prev., 10: 355-360, 2001.
37. Butkiewicz, D., Rusin, M., Enewold, L., Shields, P. G., Chorazy, M., and Harris, C. C. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 22: 593-597, 2001.
38. Sturgis, E. M., Zheng, R., Li, L., Castillo, E. J., Eicher, S. A., Chen, M., Strom, S. S., Spitz, M. R., and Wei, Q. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis (Lond.), 21: 2219-2223, 2000.
39. Vogel, U., Hedayati, M., Dybdahl, M., Grossman, L., and Nexo, B. A. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis, 22: 899-904, 2001.
40. David-Beabes, G. L., Lunn, R. M., and London, S. J. No Association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 10: 911-912, 2001.
41. Mohrenweiser, H. W., Carrano, A. V., Fertitta, A., Perry, B., Thompson, L. H., Tucker, J. D., and Weber, C. A. Refined mapping of the three DNA repair genes, ERCC1, ERCC2, and XRCC1, on human chromosome 19. Cytogenet. Cell Genet., 52: 11-14, 1989.